{"id":1276,"date":"2023-05-18T18:20:00","date_gmt":"2023-05-18T18:20:00","guid":{"rendered":"https:\/\/healthynewsusa.com\/?p=1276"},"modified":"2023-05-18T18:20:00","modified_gmt":"2023-05-18T18:20:00","slug":"the-abortion-pill-goes-back-to-court","status":"publish","type":"post","link":"https:\/\/healthynewsusa.com\/?p=1276","title":{"rendered":"The Abortion Pill Goes Back to Court"},"content":{"rendered":"
\n
\n

\n\t\tThe Host\t<\/h3>\n
\n
\n
\n\t\t\t\n\t\t<\/div>\n<\/div><\/div>\n<\/div>\n

The fate of the abortion pill mifepristone remains in jeopardy, as an appellate court panel during a hearing this week sounded sympathetic to a lower court\u2019s ruling that the FDA should not have approved the drug more than two decades ago. No matter how the appeals court rules, the case seems headed for the Supreme Court.<\/p>\n

Meanwhile, in the partisan standoff over raising the nation\u2019s debt ceiling, a key sticking point has emerged: whether to add a work requirement to the state-federal Medicaid program. Republicans are adamant about adding one; Democrats point out that, in the few states that have tried them, red tape has resulted in eligible people wrongly losing their health coverage.<\/p>\n

This week\u2019s panelists are Julie Rovner of KFF Health News, Sandhya Raman of CQ Roll Call, Rachel Roubein of The Washington Post, and Victoria Knight of Axios.<\/p>\n

Among the takeaways from this week\u2019s episode:<\/p>\n